Gastroenterology
Volume 125, Issue 6 , Pages 1670-1677 , December 2003

Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn

  • Douglas K Rex

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • Corresponding Author InformationAddress requests for reprints to: Douglas K. Rex, M.D., Indiana University Hospital 4100, 550 University Boulevard, Indianapolis, Indiana 46202, USA; fax: (317) 274-5449
    • ,
  • Oscar W Cummings

      Affiliations

    • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • Michael Shaw

      Affiliations

    • Park-Nicolette Medical Center, Minneapolis, Minnesota, USA
    • ,
  • Mark D Cumings

      Affiliations

    • Division of Gastroenterology, Walter Reed Army Medical Center, Washington, DC, USA
    • ,
  • Roy K.H Wong

      Affiliations

    • University of South Carolina, Columbia, South Carolina, USA
    • ,
  • Raj S Vasudeva

      Affiliations

    • University of South Carolina, Columbia, South Carolina, USA
    • ,
  • Donal Dunne

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • Emad Y Rahmani

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • ,
  • Debra J Helper

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA

Received 12 March 2003 ,Accepted 11 September 2003.

References 

  1. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78:1820–1828
  2. Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N. Adenocarcinoma of the esophagus and Barrett’s esophagus (a population-based study). Am J Gastroenterol. 1999;94:86–91
  3. Blot WJ, Devesa SS, Kneller RW, Graumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289
  4. Lagergren J, Bergstorm R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  5. Stein HJ, Siewert JR. Barrett’s esophagus (pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management). Dysphagia. 1993;8:276–288
  6. Altorki NK, Skinner DB. Adenocarcinoma in Barrett’s esophagus. Semin Surg Oncol. 1990;6:274–278
  7. Haggitt RC, Tryzelaar J, Ellis FH, Colcher Hl. Adenocarcinoma complicating columnar epithelial lined (Barrett’s) esophagus. Am J Clin Pathol. 1978;70:1–5
  8. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg. 1983;198:554–565
  9. Smith RR, Hamilton SR, Boitnott JK, Rogers EL. The spectrum of carcinoma arising in Barrett’s esophagus. Am J Surg Pathol. 1984;8:563–573
  10. Rosenberg JC, Budey H, Edwards RC, Singal S, Steiger Z, Sundareson AS. Analysis of adenocarcinoma in Barrett’s esophagus utilizing a staging system. Cancer. 1985;55:1353–1360
  11. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett’s esophagus. Am J Surg Pathol. 1995;19:183–191
  12. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction in Barrett’s esophagus. Gastroenterology. 1995;109:1541–1546
  13. Clark GW, Smyrk TC, Budiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett’s metaplasia the source of adenocarcinomas of the cardia?. Arch Surg. 1994;129:609–614
  14. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer. 1987;60:1094–1098
  15. Sampliner RE. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 2002;97:1888–1895
  16. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s esophagus. Br J Surg. 1988;75:760–763
  17. Cederqvist C, Nielsen J, Berthelsen A, Hansen HS. Cancer of the esophagus. II. Therapy and outcome. Acta Chir Scand. 1978;144:233–240
  18. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85:59–71
  19. Ellis FH, Gibb SP, Watkins E. Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg. 1983;198:531–540
  20. Galandiuk S, Hermann RE, Cosgrove DM, Gassman JJ. Cancer of the esophagus. The Cleveland Clinic experience. Ann Surg. 1986;203:101–108
  21. DeMeester TR, Zaninotto G, Johansson KE. Selective therapeutic approach to cancer in the lower esophagus and cardia. J Thorac Cardiovasc Surg. 1988;95:42–54
  22. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997;26:487–494
  23. Dulai G, Guha S, Kahn K, Gornbein J, Weinstein W. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma (a systematic review). Gastroenterology. 2002;122:26–33
  24. Shaheen NJ, Provenzale D, Sandler RS. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma (a review of the evidence). Am J Gastroenterol. 2002;97:1319–1327
  25. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia (adenocarcinoma versus squamous cell carcinoma). Cancer Epidemiol Biomarkers Prev. 1995;4:85–92
  26. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, et al. Adenocarcinoma of the esophagus (role of obesity and diet). J Natl Cancer Inst. 1995;87:104–109
  27. Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors of esophageal adenocarcinoma. Am J Gastroenterol. 2002;97:1930–1936
  28. Menke-Pluymers MB, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer. 1993;72:1155–1158
  29. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988;95:903–912
  30. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey Ml. Development of a digestive health status instrument (tests of scaling assumptions, structure, and reliability in a primary care population). Aliment Pharmacol Ther. 1998;12:1067–1078
  31. Dhillon S, Romero Y, Harmsen S, Beri G, Schleck C, Zinsmeister A. Concurrent validity and reproducibility characteristics of the reflux symptoms questionnaire and the reflux symptoms questionnaire 1-W. Am J Gastroenterol. 2002;97:S243
  32. Locke GR, Talley NJ, Weaver AL, Zinsmeister ARl. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–547
  33. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd edition. New York: Wiley; 2000;
  34. Hirota W, Loughney T, Lazas D, Maydonovitch CL, Rholl W, Wong RK. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction (prevalence and clinical data). Gastroenterology. 1999;116:277–285
  35. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–1536
  36. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamo-columnar junction in patients attending for diagnostic gastroscopy. Gut. 1997;41:585–589
  37. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characterisitics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol. 1996;91:1507–1511
  38. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett’s oesophagus (prevalence, diagnosis and associations). Gut. 1997;40:710–715
  39. Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett’s esophagus. Gastroenterology. 2000;119:683–690
  40. El-Zimaity HM, Graham DY. Cytokeratin subsets for distinguishing Barrett’s esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001;96:1378–1382
  41. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut. 2001;48:287–289
  42. Ransom JM, Patel GR, Cliff SA, Womble NE, Read RCl. Extended and limited types of Barrett’s esophagus in the adult. Ann Thorac Surg. 1982;33:19–27
  43. Harle IA, Finley RJ, Belsheim M, Bondy DC, Booth M, Lloyd 0D, et al. Management of adenocarcinoma in columnar-lined esophagus. Ann Thorac Surg. 1985;40:330–336
  44. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett’s esophagus. Ann Intern Med. 2000;132:612–620
  45. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histologic factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999;94:3413–3419
  46. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461–467
  47. Weston AP, Krmpotich P, Makdisi WF, Cherian R, Dixon A, McGregor DH, et al. Short segment Barrett’s esophagus. Clinical and histologic features, associated endoscopic findings, and associations with gastric intestinal metaplasia. Am J Gastroenterol. 1996;91:981–986
  48. Weston AP, Krmpotich P, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett’s esophagus. Dig Dis Sci. 1997;42:597–602
  49. Sharma P, Morales T, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short segment Barrett’s esophagus—a prospective 3 year follow-up. Am J Gastroenterol. 1997;92:2012–2016
  50. Hamilton S, Smith R, Cameron J. Prevalence and characteristics of Barrett’s esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol. 1988;19:942–948
  51. Rudolph R, Vaughan T, Storer B, Haggitt RC, Rabinovitch PS, Levine DS, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett’s esophagus. Ann Intern Med. 2000;132:612–620
  52. Schnell T, Sontag S, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett’s esophagus. Dig Dis Sci. 1992;37:137–143
  53. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy (a new technique to identify specialized intestinal metaplasia in Barrett’s esophagus). Gastrointest Endosc. 2001;53:559–565
  54. Sharma P, Weston A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia dysplasia in Barrett’s esophagus. (abstr) Gastrointest Endosc. 2001;53: AB63(329)
  55. Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc. 2000;51:560–568
  56. Kiesslich R, Hahn M, Herrmann G, Jung M. Screening for specialized columnar epithelium with methylene blue (chromoendoscopy in patients with Barrett’s esophagus and a normal control group). Gastrointest Endosc. 2001;53:47–52
  57. Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short segment Barrett’s esophagus. Gastrointest Endosc. 2001;54:289–293

☆ Supported in part by Astra-Zeneca, by the American Society for Gastrointestinal Endoscopy, and by Boston-Scientific (Microvasive).

PII: S0016-5085(03)01523-3

doi: 10.1053/j.gastro.2003.09.030

Gastroenterology
Volume 125, Issue 6 , Pages 1670-1677 , December 2003

Article Tools